Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2693-2700

  Henry, K W ^a   Nickels, J T ^a   Edlind, T D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; FENPROPIMORPH; FLUCONAZOLE; FUNGAL ENZYME; FUNGAL RNA; ITRACONAZOLE; KETOCONAZOLE; LANOSTEROL DEMETHYLASE; MICONAZOLE; PYRROLE DERIVATIVE; TERBINAFINE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TOLERANCE; FUNGAL GENETICS; FUNGUS CULTURE; GENE EXPRESSION; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEROL SYNTHESIS; YEAST;

AZOLES; CANDIDA; CULTURE MEDIA; ERGOSTEROL; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS; PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, FUNGAL; STEROLS; SUPPORT, U.S. GOV'T, P.H.S.; UP-REGULATION;

EID: 0033807662     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2693-2700.2000     Document Type: Article

References (42)

1. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily
2. Emerging disease issues and fungal pathogens associated with HIV infection
3. Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the post-squalene portion of the yeast ergosterol pathway
4. Genome-wide expression patterns in Saccharomyces cerevisiae: Comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol
5. Correlation between the sterol composition of membranes and morphology in Candida albicans
6. Transcriptional regulation of a sterol-biosynthetic enzyme by sterol levels in Saccharomyces cerevisiae
7. Multiple mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains
8. Deletion of the Candida glabrata ERG3 and ERG11 genes: Effect on cell viability, cell growth, sterol composition and antifungal susceptibility
9. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents
10. Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals
11. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in HepG2 cells
12. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells
13. Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae
14. Overexpression of ERG11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae
15. Expression of CDR1, a multidrug resistance gene of Candida albicans: Transcriptional activation by heat shock, drugs and human steroid hormones
16. The mutation T315A in Candida albicans sterol 14α-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity
17. High prevalence of antifungal resistance in Candida spp. from patients with AIDS
18. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans
19. Cloning of the late genes in the ergosterol biosynthesis pathway of Saccharomyces cerevisiae - A review
20. Biochemistry and molecular biology of sterol synthesis in Saccharomyces cerevisiae
21. Compensatory responses to inhibition of hepatic squalene synthase
22. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
23. The trailing end point phenotype in antifungal susceptibility testing is pH dependent
24. Regulation of squalene synthetase and squalene epoxidase activities in Saccharomyces cerevisiae
25. Co-ordinate regulation of low-density-ilpoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells
26. Inhibition of sterol biosynthesis by ergosterol and cholesterol in Saccharomyces cerevisiae
27. Resistance of Candida species to fluconazole
28. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections
29. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
30. Conservation between human and fungal squalene synthetases: Similarities in structure, function and regulation
31. Harnessing the power of the genome in the search for new antibiotics
32. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy
33. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
34. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
35. Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungals
36. Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae
37. Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver
38. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes
39. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: The emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA)
40. Increased mRNA levels of ERG16, CDR and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
41. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α-demethylase in Candida albicans